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ABSTRACT
Background: Helicobacter pylori (H. pylori) infection leads to inflammation of the gastric mucosa. 
It damages the gastric epithelium and related to the risk of developing gastric cancer. Over time, it may develop into 
the development of glandular atrophy and intestinal metaplasia. This study was aimed to evaluate the histological 
features of gastric mucosa, including H. pylori infection in patients with endoscopically found superficial gastritis, 
erosive gastritis and gastric ulcer. 
Method: Subjects with abdominal complaints who underwent consecutive upper gastrointestinal endoscopy 
were prospectively selected at Tugurejo Hospital between November 2004 and December 2010. Eligible subjects 
were those with endoscopic diagnosis of superficial gastritis, erosive gastritis or gastric ulcer. The biopsy 
specimens were taken from the corpus, angulus and antrum of all the patients. Giemsa and hematoxylin-eosin 
staining were used for the histological diagnosis H. pylori and gastric mucosa inflammation. 
Results: The overall prevalence of H. pylori infection in superficial gastritis, erosive gastritis 
and gastric ulcer were 24.3%. There was significant difference between H. pylori infection rate in 
antrum of patients with superficial gastritis 19.4%, erosive gastritis 26.3%, and gastric ulcer 34.7%. 
The positivity rate of glandular atrophy and intestinal metaplasia of superficial gastritis with H. pylori-positivity 
was 12.5%, 14.0%; erosive gastritis 26.3%, 16.6%; and of gastric ulcer 38.9%, 29.3%; respectively. However, 
there was no significant difference. 
Conclusion: Patients with gastric ulcer have H. pylori infection, atrophic gastritis and metaplasia intestinal 
more than superficial gastritis and erosive gastritis. Progression of the gastric ulcer to atrophic gastritis and 
intestinal metaplasia is related to H. pylori infection.
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ABSTRAK
Latar belakang: Infeksi Helicobacter pylori (H. pylori) dapat menyebabkan terjadinya peradangan pada 
mukosa lambung. Hal tersebut dapat merusak epitel lambung dan menjadi risiko terkena kanker lambung. Seiring 
dengan berjalannya waktu, atropi kelenjar lambung dan metaplasia intestinal dapat berkembang menjadi kanker 
lambung. Penelitian ini bertujuan untuk mengevaluasi histologi dari mukosa lambung meliputi infeksi H. pylori 
pada pasien dengan temuan endoskopi sebagai penyebab gastritis ringan, gastritis erosif dan ulkus lambung.
Metode: Pengumpulan data dilakukan secara prospektif dengan rancangan penelitian potong lintang. Subjek 
penelitian adalah semua pasien yang menjalani prosedur esofagogastroduodenoskopi secara konsekutif di Rumah 
Sakit Tugurejo Semarang pada November 2004-Desember 2010 dengan keluhan pada saluran cerna bagian 
atas dan ditemukan sebagai gastritis ringan, gastritis erosif atau ulkus lambung. Pengambilan biopsi dilakukan 
pada korpus, angulus dan antrum. Pewarnaan Giemsa dan Hematoxyllin Eosin dilakukan untuk mendiagnosis 
infeksi H. pylori dan inflamasi pada mukosa lambung. 
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Hasil: Secara keseluruhan diketahui prevalensi infeksi H. pylori sejumlah 24,3%. Terdapat perbedaan 
bermakna secara statistik untuk infeksi H. pylori di antrum pada gastritis superfisial 19,4%, gastritis erosif 
26,3%, dan ulkus lambung 34,7%. Infeksi H. pylori pada atropi kelenjar dan metaplasia intestinal masing-
masing ditemukan pada gastritis superfisial sebesar 12,5% dan 14,0%, pada gastritis erosif 26,3% dan 16,6%; 
dan ulkus lambung sebesar 38,9% dan 29,3%, namun secara statistik tidak terdapat perbedaan bermakna. 
Simpulan: Pasien dengan ulkus lambung mempunyai infeksi H. pylori, atropi dan metaplasia yang lebih 
banyak dibandingkan dengan gastritis superfisial dan gastritis erosif. Infeksi H. pylori dapat mempercepat 
perkembangan ulkus menjadi atropi dan metaplasia intestinal.
 
Kata kunci: infeksi Helicobacter pylori, gastritis superfisial, erosi dan ulkus
INTRODUCTION
In the early 20th century, the pathogenesis of acid-
peptic disease was believed to be related to stress and 
dietary factors. Later on, other factors such as gastric 
secretions, age, sex, smoking and alcohol consumption 
were held responsible as the cause.1 Warren and 
Marshall in 1982 discovered a spiral, flagellated 
gram-negative organism known as Helicobacter pylori 
(H. pylori) which has been implicated in the etiology 
of these diseases.2 While the prevalence of H. pylori 
is decreasing in the Western world, it still constitutes 
a significant medical burden in less industrialized 
countries, with constant higher infection rates and a 
more widespread distribution.3 The challenge now is 
to fill in the remaining gaps in our knowledge such as 
transmission routes as well as genetic preconditions, 
as antibiotic resistance increases, develop preventative 
strategies including improved hygiene conditions and 
vaccination.4-7 
Infection with H. pylori is a co-factor in the 
development of duodenal or gastric ulcers (reported to 
develop in 1 to 10% of infected patients), gastric cancer 
(0.1 to 3%) and gastric mucosa associated lymphoid 
tissue (MALT) lymphoma (< 0.01%).8,9 Infection 
with H. pylori may lead to inflammation of the gastric 
mucosa with subsequent ulceration.9 Infection is 
a major cause of chronic gastritis, a condition that 
initiates the pathogenic sequence of events leading 
to atrophic gastritis, intestinal metaplasia, dysplasia 
and subsequently cancer.8,10-14 While the bacterium is 
not a direct cause of cancer, its presence and resultant 
reduction in acid production are necessary factors 
in causation.8,15 The risk of these disease outcomes 
in infected patients varies widely among different 
populations and the great majority of patients with 
H. pylori will not have any clinically significant 
complications.16-18 
Diagnosis of H. pylori infection is done either by 
rapid urease test in biopsy specimen or microscopic 
examination and culture of the specimen or by 
other non-endoscopic methods like urea breath test, 
H. pylori stool antigen assay or anti-H. pylori 
antibodies in the serum.8,19 H. pylori eradication has 
been recommended by various consensus conferences 
and its eradication has led to marked reduction in 
peptic ulcer disease and need for further therapy.19,20-22 
H. pylori infection has worldwide distribution and 
is found to be prevalent and strongly associated 
with peptic ulcer disease and gastritis in Pakistani 
population.23 Data of H. pylori infection in superficial 
gastritis and ulcer disease in Indonesia was limited. This 
study was aimed to evaluate the histological features 
of gastric mucosa, including H. pylori infection, in 
patients with endoscopically found superficial gastritis, 
erosive gastritis and gastric ulcer. 
METHOD
A cross-sectional study was conducted. All patients 
were prospectively selected from subjects with 
abdominal complaints who underwent consecutive 
upper gastrointestinal endoscopy at Tugurejo Hospital 
Semarang between November 2004 and December 
2010. The inclusion criteria were subjects with 
endoscopic diagnosis of superficial gastritis, erosive 
gastritis and gastric ulcer. Subjects were excluded 
from the study if they had history of receiving anti-
ulcer agents or antibiotics during two weeks before 
endoscopy or had previous history of duodenal 
ulcers, or gastric surgery. All patients have given their 
informed consent prior to endoscopy.
Biopsy specimens for histological diagnosis were 
obtained endoscopically from the greater curvature of 
the lower, the upper corpus and the lesser curvature of 
the lower corpus of the stomach, according to the triple-site 
gastric biopsy method. The specimens were fixed overnight 
in buffered formalin, embedded in paraffin, cut into three 
µm thickness, and stained with hematoxylin-eosin 
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The grades of mononuclear cell and polymorpho-
nuclear cell infiltration, mucosal glandular atrophy and 
intestinal metaplasia in patients are shown in Table 3 
and 4. The grades of mononuclear cell infiltration and 
polymorphonuclear cell infiltration in gastric ulcer 
were higher than that in superficial gastritis patients 
and erosive gastritis, but it was not significantly 
different. 
The positivity rate of mucosa glandular atrophy and 
intestinal metaplasia of superficial gastritis, erosive 
gastritis, and gastric ulcer patients with H. pylori 
positivity was significantly higher in gastric ulcer than 
superficial gastritis (Table 5).
staining. In accordance with the Updated Sydney 
System, the degree of gastric mucosal inflammation 
(mononuclear and poly-morphonuclear cell infiltration), 
glandular atrophy, and intestinal metaplasia were 
classified into four grades as follows: 0 = none, 
1 = mild, 2 = moderate and 3 = severe.14 Histologically, 
H. pylori infection was considered negative if 
H. pylori were absent from all biopsy sites stained 
with hematoxylin-eosin staining. H. pylori infection 
was considered positive if at least one of the histology 
tests was positive. 
The prevalence of H. pylori infection, rates of 
gastric mucosal inflammation, polymorphonuclear cell 
infiltration, glandular atrophy and intestinal metaplasia 
were compared using the chi-square test for 4-fold 
table. The difference in grades of mononuclear cell 
infiltration, polymorphonuclear cell infiltration, 
glandular atrophy and intestinal metaplasia between 
diseases was compared by Mann-Whitney test. 
If p < 0.05 was considered statistically significant.
RESULTS 
Two hundred and sixteen patients were enrolled 
in this study consisted of 72 patients with superficial 
gastritis aged from 38 to 68 years (mean age 56.3 ± 
9.9); 72 patients with erosive gastritis aged from 38 
to 66 years (mean age 65.3 ± 10.4); 72 patients with 
gastric ulcer aged from 38 to 70 years (mean age 65.7 
± 10.8). 
Predominant sites of lesions based on endoscopical 
diagnosis are shown in Table 1. The positivity rates 
for H. pylori infection in studied patients are shown in 
Table 1. Endoscopical diagnosis and predominant sites of lesion
Endoscopical 
diagnosis
Predominant  site of location lesion 
n (%)
Corpus Antrum Corpus and antrum
Superficial gastritis 3 (4.16) 37 (51.38) 30 (41.67)
Erosive gastritis 19 (26.39) 51 (70.83) 2 (2 .78)
Gastric ulcer 16 (22.22) 47 (65.28) 9 (12.5)
Table 2. Helicobacter pylori infection identified in antrum and 
associated diseases





Table 3. The grade of gastric mucosal inflammation in patients
Diagnosis
Mononuclear (%) Polymorphonuclear (%)
p*
0 1 2 3 0 1 2 3
Superficial gastritis 44.3 30.9 10.1 14.7 72.7 3.5 4.5 19.2
0.091Erosive gastritis 3.8 27.0 23.0 43.4 36.7 3.8 10.1 52.1
Gastric ulcer 4.2 11.3 17.0 67.5 17.8 3.1 17.5 61.5
0: none; 1: mild; 2: moderate; 3: severe; *Mann-Whitney test




0 1 2 3 0 1 2 3
Superficial gastritis 77.6 18.7 2.2 1.5 85.3 4.2 4.9 5.6
0.087Erosive gastritis 62.3 13.1 10.5 14.1 81.7 8.5 3.4 6.4
Gastric ulcer 56.2 10.7 11.8 21.3 71.7 6.7 8.1 13.5
0: none; 1: mild; 2: moderate; 3: severe; *Mann-Whitney test
Table 2. There was no data of H. pylori at angulus sites 
since the pathologist had not evaluated H. pylori from 
the antrum and angulus. The prevalence of H. pylori 
infection in gastric ulcer was significantly higher than 
that of superficial gastritis and erosive gastritis.
Table 5. Glandular atrophy and intestinal metaplasia in patients with Helicobacter pylori 
infection and associated  disease
Diagnosis
Glandular atrophy Intestinal metaplasia
p*
H. pylori + (%) H. pylori + (%)
Superficial gastritis 12.5 14.0
0.038Erosive gastritis 23.6 16.6
Gastric ulcer 38.9 29.3
*Chi-square
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DISCUSSION 
H. pylori infections tend to be initiated at the antrum 
and extend proximally into the corpus along the lesser 
curvature. This study showed antrum-predominant 
gastritis. Such result is similar to the results of studies 
in Asian countries, including China, Vietnam, Thailand 
and Myanmar.24 In Japanese patients, H. pylori infection 
and chronic active gastritis progress to the corpus 
with advancing age, resulting in corpus-predominant 
gastritis. In constant, antrum gastritis will not develop 
into corpus gastritis in the Nepalese like other Asian 
populations.24 The difference of mucosal changes 
induced by H. pylori infection between the Japanese 
and other Asian populations may be correlated with the 
different incidences of gastric cancer in the Japanese 
and other Asian populations.24 Uemura et al, reported 
that among H. pylori infected Japanese patients, 
those with severe atrophy accompanying intestinal 
metaplasia, corpus-predominant gastritis or both, are 
particularly high risk.25 
Epidemiological evidence indicates that H. pylori 
infections are much more prevalent in developing 
countries than in developed nations such as the United 
States. It has been estimated that 30–40% of the 
United States population is infected with H. pylori.9,26 
H. pylori remains one of the most common worldwide 
human infections and is associated with a number 
of important upper gastrointestinal (GI) conditions 
including chronic gastritis, peptic ulcer disease, and 
gastric malignancy.26
The prevalence of H. pylori in this study is 24.3%, 
which is lower than study reports by Elseweidy et al, 
in Egypt (84%), Hashemi et al, in Iran (67.4%), and 
Khan et al, in Pakistan (85%).23,27,28 In India, H. pylori 
is positive in 38 (56.7%) asymptomatic individuals 
and in 49 (61.3%) symptomatic individuals.29 
In Jordan, H. pylori is frequent in 82% of 197 study 
subjects.30 Prevalence of H. pylori in Indonesia 
reported by Albertus et al, using polymerase chain 
reaction (PCR) to detect H. pylori is 46.7%,31 Syam 
AF et al, using rapid urea test (Pronto Dry) found 
10.2% of prevalence.32 Previous studies have shown 
that the prevalence of H. pylori infections is affected 
by several factors, including living conditions, income, 
ethnicity, socio-economic status, especially infection 
in childhood, availability of public water supplies and 
sewers, the number of family support organizations, 
and the number of rooms in the home.1-3 The reasons 
for erratic rates of H. pylori infection may be reported 
from the country. 
In comparison between H. pylori- positive and 
H. pylori-negative patients, mononuclear cell 
infiltration was more severe in H. pylori-positive 
patients with superficial gastritis, erosive gastritis 
and gastric ulcer than H. pylori-negative patients. 
We assume that it was related with the grade of 
mononuclear cell infiltration, polymorphonuclear 
cell infiltration and the grade of H. pylori infection. 
More intense bacterial infection and more severe 
polymorphonuclear cell infiltration may contribute 
more to DNA damage and promote carcinogenesis 
in patients with gastric cancer. Furthermore, chronic 
H. pylori infection is also associated with increased 
gastric cell turnover, probably of importance in 
malignant transformation.33-37
Glandular atrophy and intestinal metaplasia were 
found in more than half of H. pylori negative patients 
but were remarkably low in the H. pylori-positive 
patients. However, there was no significant difference 
between H. pylori-positive and negative patients. 
Glandular atrophy scores and intestinal metaplasia 
scores of all sites in H. pylori-infected Japanese 
patients was significantly higher compared to this 
study.24,38
 Zhang and Yamada reported that there was a tight 
link between atrophic gastritis and intestinal metaplasia 
in stomachs of Japanese patients with early gastric 
cancer.39 Occasionally, glandular atrophy and intestinal 
metaplasia tissues were found in H. pylori-negative 
patients; while in the tissues without glandular atrophy 
or intestinal metaplasia, we may found H. pylori 
positive. These findings suggest that most patients 
with intestinal metaplasia and glandular atrophy have 
been infected with H. pylori at some stage. H. pylori 
infection may provide the proper environment for 
atrophic gastritis and intestinal metaplasia to occur. 
At the final stage of the disease, gastric atrophy with 
intestinal metaplasia is not a hospitable environment 
for H. pylori. It may also associated with a dramatic 
reduction or even disappearance of the organism.40-43 
This study did not explore H. pylori strains and 
(interleukin) IL-1 polymorphisms because there is 
no facility for culture. Several H. pylori virulence 
and associated genes have been found in Western 
populations to be correlated to an increased risk of 
gastric cancer and pre-cancerous lesions.34 Moreover, 
it has been confirmed that IL-1 polymorphisms 
contributes to the gastric acid secretory response, 
facilitating H. pylori infection and subsequently 
developing clinical sequelae.43 
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CONCLUSION
Patients presenting with gastric ulcer have H. pylori 
infection, atrophic gastritis and metaplasia intestinal 
more than superficial gastritis and erosive gastritis. 
Progression of the gastric ulcer to atrophic gastritis and 
intestinal metaplasia is related to H. pylori infection.
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